| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |